Bleakley Financial Group, LLC Ionis Pharmaceuticals Inc Transaction History
Bleakley Financial Group, LLC
- $3.12 Trillion
- Q1 2025
A detailed history of Bleakley Financial Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 22,284 shares of IONS stock, worth $839,438. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,284
Previous 16,942
31.53%
Holding current value
$839,438
Previous $592 Million
13.51%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$617 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$609 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$466 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$389 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$317 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.35B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...